AGL 34.89 Decreased By ▼ -0.31 (-0.88%)
AIRLINK 129.55 Increased By ▲ 6.32 (5.13%)
BOP 5.15 Increased By ▲ 0.11 (2.18%)
CNERGY 3.84 Decreased By ▼ -0.07 (-1.79%)
DCL 8.09 Decreased By ▼ -0.06 (-0.74%)
DFML 44.34 Increased By ▲ 0.12 (0.27%)
DGKC 75.25 Increased By ▲ 0.90 (1.21%)
FCCL 24.60 Increased By ▲ 0.13 (0.53%)
FFBL 49.30 Increased By ▲ 1.10 (2.28%)
FFL 8.85 Increased By ▲ 0.07 (0.8%)
HUBC 142.50 Decreased By ▼ -3.35 (-2.3%)
HUMNL 10.50 Decreased By ▼ -0.35 (-3.23%)
KEL 3.97 Decreased By ▼ -0.03 (-0.75%)
KOSM 7.90 Decreased By ▼ -0.10 (-1.25%)
MLCF 33.00 Increased By ▲ 0.20 (0.61%)
NBP 56.85 Decreased By ▼ -0.30 (-0.52%)
OGDC 144.50 Decreased By ▼ -0.85 (-0.58%)
PAEL 25.50 Decreased By ▼ -0.25 (-0.97%)
PIBTL 5.78 Increased By ▲ 0.02 (0.35%)
PPL 116.30 Decreased By ▼ -0.50 (-0.43%)
PRL 24.05 Increased By ▲ 0.05 (0.21%)
PTC 11.05 No Change ▼ 0.00 (0%)
SEARL 58.80 Increased By ▲ 0.39 (0.67%)
TELE 7.48 Decreased By ▼ -0.01 (-0.13%)
TOMCL 41.15 Increased By ▲ 0.05 (0.12%)
TPLP 8.65 Increased By ▲ 0.34 (4.09%)
TREET 15.15 Decreased By ▼ -0.05 (-0.33%)
TRG 54.55 Decreased By ▼ -0.65 (-1.18%)
UNITY 27.88 Increased By ▲ 0.03 (0.11%)
WTL 1.31 Decreased By ▼ -0.03 (-2.24%)
BR100 8,646 Increased By 74.6 (0.87%)
BR30 27,117 Decreased By -158.3 (-0.58%)
KSE100 82,136 Increased By 677.1 (0.83%)
KSE30 26,034 Increased By 233.8 (0.91%)
Business & Finance

Moderna sees $18.4bn in sales from COVID-19 vaccine in 2021

  • Moderna also said Chief Medical Officer Tal Zaks would leave the company in late September.
  • Moderna on Wednesday said it was expecting to produce 700 million doses in 2021, while attempting to scale up production to as much as 1 billion doses.
Published February 25, 2021

Moderna Inc said on Thursday it was expecting to post $18.4 billion in sales from its COVID-19 vaccine this year.

Pfizer Inc, which makes the only other vaccine authorized for emergency use in the United States so far, said earlier this month that it was expecting to record sales of about $15 billion in 2021 from the coronavirus vaccine that it makes with German partner BioNTech.

Moderna also said Chief Medical Officer Tal Zaks would leave the company in late September.

Moderna on Wednesday said it was expecting to produce 700 million doses in 2021, while attempting to scale up production to as much as 1 billion doses.

Comments

Comments are closed.